9,143
Total Claims
$3.8M
Drug Cost
2,220
Beneficiaries
$1,732
Cost/Patient
Peer Comparison vs. 13,195 Dermatology providers
+43%
Cost per patient vs peers
$1,732 vs $1,209 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 8,321 claims · $1.9M
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Tacrolimus | 1,437 | $701K |
| Risankizumab-Rzaa | 29 | $611K |
| Secukinumab | 33 | $315K |
| Apremilast | 53 | $266K |
| Pimecrolimus | 295 | $197K |
| Clobetasol Propionate | 885 | $187K |
| Diflorasone Diacetate | 221 | $167K |
| Calcipotriene | 422 | $152K |
| Diclofenac Potassium | 74 | $97K |
| Mupirocin Calcium | 259 | $79K |
| Fluocinonide | 436 | $51K |
| Doxycycline Hyclate | 590 | $45K |
| Metronidazole | 365 | $41K |
| Halobetasol Propionate | 231 | $41K |
| Meloxicam, Submicronized | 75 | $35K |
Prescribing Profile
52
Unique Drugs
Patient Profile
73
Avg Age
56%
Female
1.79
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About